Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OLMA

Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OLMA
DateTimeSourceHeadlineSymbolCompany
05/18/20225:05AMTipRanksLifeSci Capital Thinks Olema Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OLMAOlema Pharmaceuticals Inc
05/15/20229:21AMTipRanksJ.P. Morgan Thinks Olema Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OLMAOlema Pharmaceuticals Inc
05/11/20225:03AMTipRanksAnalysts Offer Insights on Healthcare Companies: and Olema Pharmaceuticals (OLMA)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/10/20226:26AMTipRanksOlema Pharmaceuticals (OLMA) Gets a Hold Rating from H.C. WainwrightNASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20224:49PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20224:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20224:30PMGlobeNewswire Inc.Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
05/03/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
04/28/20224:39PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OLMAOlema Pharmaceuticals Inc
04/18/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
04/04/20227:30AMGlobeNewswire Inc.Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
03/14/20224:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/08/20224:35PMGlobeNewswire Inc.Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022NASDAQ:OLMAOlema Pharmaceuticals Inc
03/06/20228:01AMTipRanksJ.P. Morgan Thinks Olema Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OLMAOlema Pharmaceuticals Inc
03/03/20224:39PMEdgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/28/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
02/22/20227:30AMGlobeNewswire Inc.Olema Oncology to Present at Cowen 42nd Annual Health Care ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
02/14/20225:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/14/20223:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/11/20221:27PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/10/20224:50PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/10/20229:07AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/04/20224:28PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/03/20225:00PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
01/31/20227:30AMGlobeNewswire Inc.Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical OfficerNASDAQ:OLMAOlema Pharmaceuticals Inc
01/04/20227:30AMGlobeNewswire Inc.Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
12/14/20214:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
12/14/20214:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
12/14/20218:55AMTipRanksJefferies Maintains Their Buy Rating on Olema Pharmaceuticals (OLMA)NASDAQ:OLMAOlema Pharmaceuticals Inc
12/01/20214:09PMTipRanksHas Olema Stock Hit Bottom? JPMorgan Sees a Silver LiningNASDAQ:OLMAOlema Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OLMA